Cartesian Therapeutics, Inc. (RNAC)
6.72
-0.06
(-0.88%)
USD |
NASDAQ |
Nov 06, 09:58
Cartesian Therapeutics Price : 6.72 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 6.85 | 6.91 | 6.46 | 6.78 | 184785.0 |
| Nov 04, 2026 | 6.64 | 7.158 | 6.542 | 6.82 | 80642.00 |
| Nov 03, 2026 | 6.37 | 6.70 | 6.37 | 6.41 | 97715.00 |
| Nov 02, 2026 | 6.49 | 6.680 | 6.20 | 6.34 | 114729.0 |
| Oct 30, 2026 | 6.72 | 6.755 | 6.44 | 6.49 | 78801.00 |
| Oct 29, 2026 | 6.76 | 6.97 | 6.63 | 6.75 | 112514.0 |
| Oct 28, 2026 | 6.43 | 6.73 | 6.29 | 6.69 | 113926.0 |
| Oct 27, 2026 | 6.26 | 6.55 | 6.13 | 6.46 | 118819.0 |
| Oct 26, 2026 | 6.25 | 6.32 | 6.07 | 6.28 | 105633.0 |
| Oct 23, 2026 | 6.38 | 6.52 | 6.11 | 6.18 | 85902.00 |
| Oct 22, 2026 | 6.33 | 6.642 | 6.24 | 6.41 | 89200.00 |
| Oct 21, 2026 | 6.42 | 6.706 | 6.40 | 6.42 | 105973.0 |
| Oct 20, 2026 | 6.09 | 6.525 | 6.071 | 6.395 | 168585.0 |
| Oct 19, 2026 | 6.28 | 6.55 | 6.01 | 6.08 | 201517.0 |
| Oct 16, 2026 | 6.62 | 6.65 | 6.25 | 6.27 | 112780.0 |
| Oct 15, 2026 | 6.39 | 6.776 | 6.39 | 6.58 | 86784.00 |
| Oct 14, 2026 | 6.55 | 6.69 | 6.33 | 6.34 | 173399.0 |
| Oct 13, 2026 | 6.98 | 7.02 | 6.565 | 6.57 | 218574.0 |
| Oct 12, 2026 | 7.03 | 7.147 | 6.95 | 6.99 | 107799.0 |
| Oct 09, 2026 | 6.87 | 7.165 | 6.851 | 7.055 | 114547.0 |
| Oct 08, 2026 | 6.68 | 6.82 | 6.50 | 6.82 | 214397.0 |
| Oct 07, 2026 | 6.70 | 6.84 | 6.60 | 6.68 | 86412.00 |
| Oct 06, 2026 | 7.15 | 7.23 | 6.75 | 6.75 | 171212.0 |
| Oct 05, 2026 | 7.36 | 7.425 | 7.11 | 7.14 | 226262.0 |
| Oct 02, 2026 | 7.32 | 8.05 | 7.29 | 7.36 | 200379.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 57.57 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.97 |
| Anixa Biosciences, Inc. | 3.02 |
Price Related Metrics
| PS Ratio | 123.67 |
| PEG Ratio | -0.0014 |
| Earnings Yield | -88.38% |
| Market Cap | 201.86M |
| PEGY Ratio | -0.0014 |